At Alkermes, our purpose and values guide how we work together and how we show up for the patients, families and communities we serve. Across #TeamAlkermes, #GreatScience, Deep Compassion and Real Impact reflect what drives us forward.
Alkermes
Biotechnology Research
Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience.
About us
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders, including addiction, serious mental illness and sleep disorders. With our portfolio of marketed medicines and investigational pipeline candidates, we seek to make a meaningful difference the way people manage these chronic diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized. Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions. Our core values also guide and define our culture and contribute to our recognition as an employer of choice in the biotech industry. In 2025, Alkermes was proud to be recognized as: - A Best Workplace in BioTech and Pharmaceuticals by Fortune Magazine; - A Top Place to Work in Massachusetts by the Boston Globe; - A Best Place to Work in Ireland by the Sunday Times Ireland; and - A Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier Alkermes is headquartered in Ireland, and also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
- Website
-
https://www.alkermes.com/
External link for Alkermes
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Dublin
- Type
- Public Company
- Founded
- 1987
- Specialties
- Pharma, Pharmaceutical, Sales, Marketing, IT, CNS, Addiction, Information technology, Human Resources, Sales, District Sales, Regional Sales, Research & Development, R&D, Manufacturing, Medical Affairs, serious mental illness, biotech, addiction, narcolepsy, neuroscience, sleep disorders, and biotech
Locations
-
Primary
Get directions
Connaught House
1 Burlington Road
Dublin, IE
-
Get directions
900 Winter St
Waltham, Massachusetts 02451, US
-
Get directions
265 Olinger Circle
Wilmington, OH 45177, US
Employees at Alkermes
Updates
-
Members of #TeamAlkermes' Human Resources team attended Leap HR's Life Sciences East Conference last week in Boston, where Steve Schiavo, SVP of HR participated in a panel discussion. To learn more about life on #TeamAlkermes, head to our website for a full list of our open positions. www.alkermes.com/careers
-
-
Did you know that the focus areas for this year’s Alkermes Pathways Research Awards® have expanded to include #narcolepsy and #idiopathichypersomnia? Visit our website to learn more and submit a letter of intent before tomorrow's deadline. https://lnkd.in/ehzWbSe9
-
-
While #ADHD can be more challenging to diagnose in adults than children, both populations are affected by this condition. #ADHDAwarenessMonth
-
We’re proud to share that Alkermes has been named 7th on Fortune’s Best Workplaces in BioPharma. Inclusion on this list for the third consecutive year reflects the culture #TeamAlkermes builds together: collaborative, purpose-driven and focused on pursuing #GreatScience to make a real impact for patients and communities. https://lnkd.in/eU6ydQ5M
-
The countdown until #SleepEurope is on! We're one week away from joining the sleep community in the Netherlands at European Sleep Research Society's annual meeting, where we will present new research from our #narcolepsy and #IdiopathicHypersomnia clinical development programs. Read more in the release: https://lnkd.in/ech8TRJH
-
Today is World Mental Health Day, a day aimed at raising awareness, advancing mental health education, and driving positive change in how we discuss mental health. One meaningful way to honor this day? Taking time to recharge, seek support, or simply slow down. Prioritizing your mental well-being isn’t a luxury; it’s essential. The World Health Organization shares practical strategies and resources to support your mental well-being. #WorldMentalHealthDay https://lnkd.in/gHMwyqb
-
There’s one week left to submit your Letter of Intent for this year’s Pathways Research Awards® cycle! Head to our website to learn more. https://lnkd.in/ehzWbSe9
-
-
Mental Illness Awareness Month is a time to raise understanding, challenge misconceptions and stand up against stigma. A meaningful way to support mental health is learning the different types of stigma people face, including public, internalized, and structural stigma, and how we can all play a role in reducing them. The American Psychiatric Association offers a helpful resource that breaks down the various forms of mental health stigma and provides actionable strategies for change. https://lnkd.in/dsUmfcs #MentalIllnessAwarenessWeek Source: American Psychiatric Association
-
